Subclinical hyperthyroidism and pregnancy outcomes

Obstetrics and Gynecology

Volumn 107, Issue 2, 2006, Pages 337-341

  Casey, Brian M ^a   Dashe, Jodi S ^a   Wells, C Edward ^a   McIntire, Donald D ^a   Leveno, Kenneth J ^a   Cunningham, F Gary ^a  

^a Department of Obstetrics and Gynecology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BLOOD; FEMALE; HUMAN; HYPERTHYROIDISM; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREVALENCE; AFRICAN AMERICAN; APGAR SCORE; BIRTH WEIGHT; BODY MASS; CAUCASIAN; DISEASE SEVERITY; FETUS DEATH; GESTATIONAL AGE; HISPANIC; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; NEWBORN MORBIDITY; NEWBORN MORTALITY; OUTCOMES RESEARCH; PARITY; PERINATAL MORTALITY; PREECLAMPSIA; PRENATAL CARE; PRIORITY JOURNAL; RACE DIFFERENCE; SCREENING TEST; THYROID DISEASE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADULT; FEMALE; HUMANS; HYPERTHYROIDISM; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREVALENCE; THYROTROPIN;

EID: 33645452281     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/01.AOG.0000197991.64246.9a     Document Type: Article

References (28)

1. Surks MI, Ortiz E, Daniels GH, Sawin CT, Nananda F, Cobin RH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004;291:228-38.
2. Marqusee E, Haden ST, Utiger RD. Subclinical thyrotoxicosis. Endocrinol Metab Clin North Am 1998;27:37-49.
3. Papi G, Pearce EN, Braverman LE, Betterle C, Roti E. A clinical and therapeutic approach to thyrotoxicosis with thyroid-stimulating hormone suppression only. Am J Med 2005;118:349-61.
4. Davis LE, Leveno KJ, Cunningham FG. Hypothyroidism complicating pregnancy. Obstet Gynecol 1988;72:108-12.
5. Davis LE, Lucas MJ, Hankins GD, Roark ML, Cunningham FG. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 1989;160:63-70.
6. Leung AS, Millar LK, Koonings PP, Montoro M, Mestman JH. Perinatal outcomes in hypothyroid pregnancies. Obstet Gynecol 1993;81:349-53.
7. Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 1994;84:946-9.
8. Sheffield JS, Cunningham FG. Thyrotoxicosis and heart failure that complicate pregnancy. Am J Obstet Gynecol 2004;190:211-7.
9. Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Leveno KJ, Cunningham FG. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2005;105:239-45.
10. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999;341:549-55.
11. Dashe JS, Casey BM, Wells CE, McIntire DD, Byrd W, Leveno KJ, et al. Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges. Obstet Gynecol 2005;106:753-7.
12. McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 1999;340:1234-8.
13. Cunningham FG, editor. Williams obstetrics. 22nd ed. New York (NY): McGraw Hill; 2005. p. 764.
14. Koster KJ, McIntire DD, Leveno KJ. Recurrence of mild malformations and dysplasias. Obstet Gynecol 2003;102:363-6.
15. Hosmer DW, Lemeshow S. Applied logistic regression. New York (NY): John Wiley & Sons; 1989.
16. Hollowell JG, Staehling NW, Flanders S, Hannon WH, Gunter EQ, Spencer CA, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489-99.
17. Benn PA, Clive JM, Collins R. Medians for second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; difference between races or ethnic groups. Clin Chem 1997;43:333-7.
18. Srivasta B, Srivatsa S, Johnson KL, Samura O, Lee SL, Bianchi DW. Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study. Lancet 2001;358:2034-8.
19. Adams KM, Nelson JL. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA 2004;297:1127-31.
20. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Relationship of thyroid function with body mass index, leptin, insulin sensitivity, and adiponectin in euthyroid obese women. Clin Endocrinol (Oxf) 2005;62:487-91.
21. Davis PJ, Davis FB. Nongenomic actions of thyroid hormone on the heart. Thyroid 2002;12:459-66.
22. Danzi S, Klein I. Thyroid hormone and the cardiovascular system. Minerva Endocrinol 2004;29:139-50.
23. Easterling TR, Schmucker BC, Carlson KL, Millard SP, Benedetti TJ. Maternal hemodynamics in pregnancies complicated by hyperthyroidism. Obstet Gynecol 1991;78:348-52.
24. Woeber KA. Observations concerning the natural history of subclinical hyperthyroidism. Thyroid 2005;15:687-91.
25. Perelman AH, Clemons RD. The fetus in maternal hyperthyroidism. Thyroid 1992;2:225-8.
26. Biondi B, Palmieri EA, Klain M, Schlumberger M, Filetti S, Lombardi G. Subclinical hyperthyroidism: clinical features and treatment options. Eur J Endocrinol 2005;152:1-9.
27. Lao TT. Thyroid disorders in pregnancy. Curr Opin Obstet Gynecol 2005;17:123-7.
28. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT. Consensus Statement #1. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. Thyroid 2005;15:24-8.